• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Qubetics: $1 Million Raised in One Day - What's Behind the Success?

user avatar

by Giorgi Kostiuk

a year ago


Qubetics has garnered significant attention by achieving the $1 million mark within a single day during its exclusive presale. This milestone underscores investor confidence and the project's promising prospects.

Presale Success: Qubetics Raises $1 Million in a Day

Qubetics launched its presale for whitelisted members with remarkable success, reaching $1 million within 24 hours. This overwhelming response highlights strong belief in Qubetics' potential to solve real-world issues using blockchain technology. The presale is now open to the public.

Revolutionizing Cross-Border Payments with Qubetics

One of Qubetics' standout features is its solution for cross-border payments. By leveraging blockchain technology, Qubetics enables near-instant global fund transfers, reducing costs and eliminating intermediaries. This makes it attractive for businesses and freelancers who need quick and cost-effective transactions.

A Glimpse into the Future: What's Next for Qubetics

Traditional cross-border payments often involve high fees and lengthy delays. Qubetics offers an alternative, ensuring transparent and secure transactions via blockchain. This positions Qubetics as a promising leader in the payment technology industry.

The success of the presale and the innovative solutions make Qubetics a promising project in the blockchain space. With growing investor confidence and community support, the future looks bright for this platform.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.